PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax
PLOS Neglected Tropical Diseases · 14.05.2026 · 20 (5) · e0013663
DOI: 10.1371/journal.pntd.0013663 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 14.05.2026. Verfasst von Paulo C Manrique-Valverde und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Plasmodium vivax, Malaria, Vivax. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill and Melinda Gates Foundation, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Plasmodium vivax is the main cause of malaria outside of sub-Saharan Africa, and in many settings it presents significant challenges to malaria elimination efforts. Despite some control successes in the Americas, regional annual case counts of malaria have increased by over 25% between 2014 and 2023, largely driven by P. vivax. Genomic surveillance can play a key role in understanding the extent to which disease persistence represents indigenous transmission as opposed to introduction of new strains through migration, and whether specific variants evade control measures. Efforts to make P. vivax genomic surveillance more cost-effective have led to the development of targeted sequencing-based methods, which strike a varying balance between assay sensitivity and breadth/informativeness. We introduce two new highly sensitive multiplexed amplicon sequencing panels for P. vivax : PvGTSeq and PvCRiSP. PvGTSeq requires selective whole-genome amplification (sWGA) and contains 249 amplicons—36 for antimalarial resistance and 213 for population structure—optimized for Latin America but applicable to all continents. PvCRiSP features four highly polymorphic amplicons that operate without sWGA and is designed to estimate complexity of infection (COI), identify instances of clonal transmission, and characterize recurrent episodes. Both panels use a single multiplex PCR with non-proprietary reagents, achieve ≥75% amplicon recovery at parasitemias as low as five parasites/μL, and PvCRiSP remains effective with low quality DNA. PvGTSeq showed high sequencing accuracy (error rate 3.85e-4% - 2.87e-3%), and both panels efficiently detected alleles from minority clones in simulated polyclonal infections. We validated both panels with samples from Colombia, Guyana, Honduras, Panama, and Venezuela, and performed in-silico assessments using data from 16 countries worldwide, confirming that these two panels have high power to discriminate samples and assign global geographic origin to imported cases. These panels will therefore be useful tools for P. vivax molecular surveillance in diverse geographic settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
- Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, United States of America.
- Malaria Vaccine and Drug Development Center, Cali, Colombia.
- Caucaseco Scientific Research Center, Cali, Colombia.
- Universidad de Panamá, Panamá, República de Panamá.
- Departamento de Investigación en Parasitología, Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES), Panamá, República de Panamá.
ORCID-Profile: Paulo C Manrique-Valverde
Förderung
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Manrique-Valverde, P. C., Hasund, C. M., Kelley, K. A., Amaya-Romero, J. E., Arévalo-Herrera, M., Brosula, R., Calzada, J. E., Chenet, S. M., Corredor, V., Early, A. M., Fontecha, G., Forero-Peña, D. A., Herrera, S., Lana, J. T., Laws, M., Niles-Robin, R., Obaldia, N., Santamaria, A. M., Schwabl, P., …, & Neafsey, D. E. (2026). PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax. PLOS Neglected Tropical Diseases, 20(5), e0013663. https://doi.org/10.1371/journal.pntd.0013663
Vancouver
Manrique-Valverde PC, Hasund CM, Kelley KA, Amaya-Romero JE, Arévalo-Herrera M, Brosula R, et al. PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax. PLOS Neglected Tropical Diseases. 2026;20(5):e0013663. doi:10.1371/journal.pntd.0013663
BibTeX
@article{ManriqueValverde2026,
author = {Manrique-Valverde, Paulo C and Hasund, Chloe M and Kelley, Katrina A and Amaya-Romero, Jorge-Eduardo and Arévalo-Herrera, Myriam and Brosula, Raphael and Calzada, Jose E and Chenet, Stella M and Corredor, Vladimir and Early, Angela M and Fontecha, Gustavo and Forero-Peña, David A and Herrera, Sócrates and Lana, Justin T and Laws, Margaret and Niles-Robin, Reza and Obaldia, Nicanor and Santamaria, Ana M and Schwabl, Philipp and Auburn, Sarah and Neafsey, Daniel E},
title = {PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {5},
pages = {e0013663},
doi = {10.1371/journal.pntd.0013663}
}
EUVIMED